Citation When referring to this article, please cite it as S. de Costa, “Raplixa case study: Enabling an innovative drug presentation through aseptic spray drying” sidebar to “Exploring the Use of ...

EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6. The expansion cohort for pancreatic ductal ...

A new study by researchers at Case Western Reserve University School of Medicine reveals that a chemical used in the diabetes drug Ozempic and the weight-management drug Wegovy is not associated with ...

Patients at high risk for developing Type 2 diabetes may be able to take a drug, called pioglitazone, to prevent the disease. The study invoveld patients with prediabetes, or abnormally high blood ...

EBC-129 is an antibody-drug ... Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual ...